Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Lifevantage Corp reported the three months ended March 31, 2026 results: revenue $43.7 million, net income $1.4 million, EPS $0.11 per diluted share. Guidance lowered.
- Period
- the three months ended March 31, 2026
- Revenue
- $43.7 million
- Net income
- $1.4 million
- EPS
- $0.11 per diluted share
- Guidance
- lowered
- Result
- reported results
Exact text from the filing
For the third quarter ended March 31, 2026, the Company reported revenue of $43.7 million, a 25.2% decrease compared to revenue of $58.4 million in the third quarter of fiscal 2025. Revenue in the Americas region for the third quarter of fiscal 2026 decreased 28.9% primarily due to declines in sales of the MindBody GLP-1 System Ò , partially offset by sales of LoveBiome, which the Company acquired in October 2025. Revenue in the Asia/Pacific & Europe region decreased 7.7%; on a constant currency basis, revenue in the Asia/Pacific & Europe region decreased approximately 8.9%. Gross profit for the third quarter of fiscal 2026 was $34.5 million, or 79.0% of revenue, compared to $47.3 million, or 81.0% of revenue, for the same period in fiscal 2025. The decrease in gross profit as a percentage of revenue was primarily due to an allowance for inventory obsolescence related to the MindBody GLP-1 System Ò , along with increases in shipping and warehouse related expenses. Adjusted for the allo
View on SEC.gov